VENATORX PHARMACEUTICALS, INC. (“Venatorx”) provides the materials on its website for general informational, educational, and disease awareness purposes. Although accessible by Internet users outside of the U.S., the website and its content are intended strictly for access and use by U.S. residents only.
THE CONTENT ON THE VENATORX WEBSITE IS PROVIDED “AS IS” AND “AS AVAILABLE.” VENATORX MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, CREATED BY LAW, CONTRACT OR OTHERWISE, INCLUDING BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE OR NON-INFRINGEMENT. VENATORX MAKES NO REPRESENTATIONS OR WARRANTIES THAT ACCESS TO THE WEBSITE WILL BE AVAILABLE ON A CONTINUOUS BASIS, UNINTERRUPTED, SECURE, OR THAT THE INFORMATION CONTAINED ON THE WEBSITE WILL BE TIMELY, COMPLETE OR ERROR FREE.
The website contains information concerning Venatorx and its products that may be useful to our customers, patients, investors, employees and shareholders as well as the general public. Venatorx makes no representations or warranties and assumes no responsibility or liability as to the accuracy, completeness, reliability or usefulness of any information contained on the website. Further, Venatorx expressly disclaims any obligation or duty to update or correct information contained on the website. Venatorx assumes no liability or responsibility for any errors or omissions in the content of the website. Venatorx reserves the right to make additions, deletions or modifications to the information or materials on the website at any time. You assume the sole and complete risk of using this website.
The information presented on our website is not intended to provide medical advice or to provide instructions on the use of our products, and should not be relied upon as the basis of any health-care decision. This information is not intended to replace informed medical advice from your qualified health-care provider regarding any questions or concerns you may have about your health or about the potential beneficial uses and possible adverse effects of any health-care product.
EACH PERSON ASSUMES FULL RESPONSIBILITY AND ALL RISKS ARISING FROM ACCESS AND USE OF THE WEBSITE. IN NO EVENT SHALL VENATORX OR ITS SUBSIDIARIES, AFFILIATES, AND RELATED COMPANIES, AND EACH OF THEIR RESPECTIVE OFFICERS, DIRECTORS, EMPLOYEES, SHAREHOLDERS, AGENTS, REPRESENTATIVES, BUSINESS PARTNERS, INFORMATION PROVIDERS AND LICENSORS AND THEIR RESPECTIVE SUCCESSORS AND ASSIGNS BE LIABLE FOR ANY DAMAGES OF ANY KIND OR NATURE, INCLUDING, BUT NOT LIMITED TO, DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, EXEMPLARY, SPECIAL (INCLUDING LOSS OF PROFIT), PUNITIVE OR OTHER DAMAGES ARISING FROM OR IN CONNECTION WITH THE EXISTENCE, ACCESS OR USE OF THE WEBSITE, REGARDLESS OF WHETHER VENATORX OR ANY OF THE OTHER ENTITIES OR PERSONS LISTED ABOVE HAS BEEN ADVISED AS TO THE POSSIBILITY OF SUCH DAMAGES.
We do not warrant that the functions or informational materials contained in or accessed through our website are free of computer viruses or other harmful components. Although we make a good faith effort to update the content of our website periodically, we do not have a duty to update information contained in our website, and we will not be liable for any failure to update such information.
WE ARE NOT PROVIDING INVESTMENT ADVICE NOR SOLICITING OFFERS.
Nothing in this website constitutes investment advice, including without limitation, our SEC filings. We provide investor relations materials for your convenience and information only. In addition, our website content is not an offer to sell or a solicitation of an offer to buy any security.
Various statements made in this website are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those which express plan, anticipation, intent, contingency, goals, targets or future development and/or otherwise are not statements of historical fact. We have based these forward-looking statements on our current expectations and projections about future events and they are subject to risks and uncertainties known and unknown which could cause actual results and developments to differ materially from those expressed or implied in such statements. These forward-looking statements include statements about the following:
In some cases, You can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “target,” “goal,” “continue,” or the negative of such terms or other similar expressions. Venatorx Incorporated’s performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as other risks and uncertainties.
Given the uncertainties affecting pharmaceutical companies in the development stage, you are cautioned not to place undue reliance on any such forward-looking statements, any of which may turn out to be wrong due to inaccurate assumptions, unknown risks, uncertainties or other factors. Venatorx Pharmaceuticals, Inc. undertakes no obligation to (and expressly disclaim any such obligation to) publicly update or revise the statements made herein or the risk factors that may relate thereto whether as a result of new information, future events or otherwise.
All information and material contained in and offered through the Venatorx website is protected to the fullest extent possible by copyright and trademark laws, as well as other state, national, and international laws and regulations. Nothing contained in this website shall be construed as granting a license or other rights under any patent, trademark, copyright or other intellectual property of Venatorx or any third party. The contents of and all materials distributed in conjunction with the website are Copyright © 2009-2020 Venatorx Pharmaceuticals, Inc. or its licensors or suppliers, all rights reserved. Venatorx also owns a copyright in the website as a collective work and/or compilation, and in the selection, coordination, arrangement, and enhancement of such content. Republication or citation of any content generated by the website without Venatorx’s prior written consent is expressly prohibited.
The VENATORX™ and the VENATORX PHARMACEUTICALS, INC. marks, and all product names, whether or not appearing in large print, italics or with the trademark symbol, are trademarks of Venatorx Pharmaceuticals, Inc., its affiliates, related companies or its licensors or collaboration partners unless otherwise noted herein and any use of such marks without the express written permission of Venatorx is strictly prohibited. The trademark MENINGITEC is the property of Pfizer and its related companies, and is now under exclusive license by Venatorx. The trademark HIBTITER is the property of Wyeth and its related companies, and is used under exclusive license by Venatorx. Unauthorized use of any material contained on this website may violate copyright laws, trademark laws, trade secret laws, the laws of privacy and publicity, and communications regulations and statutes, among other laws and regulations. Please be aware that Venatorx actively and aggressively enforces its intellectual property rights to the fullest extent allowed by applicable laws.
COPYRIGHT OWNERS’ RIGHTS UNDER THE DIGITAL MILLENNIUM COPYRIGHT ACT OF 1998
The Digital Millennium Copyright Act of 1998 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under US copyright law. If you believe in good faith that materials hosted by Venatorx infringe your copyright, you (or your agent) may send us a notice requesting that the materials be removed, or access to them be blocked. If you believe in good faith that a notice of copyright infringement has been wrongly filed against you, the DMCA permits you to send us a counter-notice. Notices and counter-notices must meet statutory requirements imposed by the DMCA. One place to find more information on the DMCA is the U.S. Copyright Office’s website. Notices and counter-notices for the website should be sent to General Counsel, Venatorx Pharmaceuticals, Inc., 74 E Swedesford Road, Suite 100, Malvern, PA 19355.
From time to time, we may provide links to certain other third-party websites merely as a convenience for users of our website. These websites are maintained on third-party servers and are not under the control of Venatorx. Access to such third-party websites is at the user’s own risk and Venatorx is not responsible for the content, the accuracy or reliability of the information, or the quality of products or services provided by these third-party websites. Inclusion of such links to third-party websites does not constitute an endorsement, approval, or guarantee by us of any third party, any website, product or service provided by any third party, or the accuracy of the contents of any linked websites (including without limitation any of the opinions and predictions of any financial analysts with respect to Venatorx or any of its securities). We expressly disclaim any responsibility for the content of any third-party websites linked to our website. We urge you to use discretion when you access and/or rely on any third-party websites linked to our website.
|You are using a browser that is not supported. Please consider changing your browser